In new guidelines, the WHO and CDC stress that women should not be denied access to progestin-only injectables. The CDC recommendations for other hormonal contraceptive methods remain unchanged.
WHO and the CDC have issued new recomendations on progestin-only injectables in women who are at high risk for HIV infection. Highlights here.
References1. World Health Organization (WHO). Can women who are at high risk of acquiring HIV, safely use hormonal contraception? http://www.who.int/reproductivehealth/topics/family_planning/hormonal-contraception-hiv/en/2. Tepper NK, Krashin JW, Curtis KM, Cox S, et al. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection. MMWR Morb Mortal Wkly Rep. 2017 Sep 22;66(37):990-994. 3. Polis CB, Curtis KM, Hannaford PC, et al. An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women. AIDS. 2016;30:2665â834. Hofmeyr GJ, Singata-Madliki M, Lawrie TA, Bergel E, Temmerman M. Effects of injectable progestogen contraception versus the copper intrauterine device on HIV acquisition: sub-study of a pragmatic randomised controlled trial. J Fam Plann Reprod Health Care. 2017;43:175â180.